Age-Stratified ED9 5 of Remimazolam Tosilate for Moderate Sedation in Pediatric Patients: A Biased Coin Design Study

Bingqing Zhu1, Wenjun Meng1, Kunyun Pan1

  • 1Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.

Insights

This study determined age-specific effective doses of remimazolam tosilate for moderate sedation in children. Toddlers required higher doses, and closer monitoring for bradycardia is advised.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Clinical Trials

Background:

  • Pediatric sedation presents challenges due to age-related physiological differences.
  • Establishing safe and effective sedative doses for children is crucial.

Purpose of the Study:

  • To determine the age-stratified 95% effective dose (ED95) of remimazolam tosilate for moderate sedation in pediatric patients.
  • To identify age-specific dosing guidelines for remimazolam tosilate in children aged 1-12 years.

Main Methods:

  • A biased coin design up-and-down sequential method was used to determine the ED95 in three pediatric age groups (toddlers, preschoolers, school-aged children).
  • Sedation success was defined as a Modified Observer's Assessment of Alertness and Sedation (MOAA/S) score ≤ 3.
  • Doses were adjusted based on patient response, and perioperative variables and adverse events were monitored.

Main Results:

  • The estimated ED95 of remimazolam tosilate was 0.415 mg·kg⁻¹ in toddlers, 0.389 mg·kg⁻¹ in preschoolers, and 0.362 mg·kg⁻¹ in school-aged children.
  • Toddlers exhibited the longest median wake-up time (32.5 min).
  • Adverse events were infrequent, with bradycardia and oxygen desaturation observed in 5.8% of patients.

Conclusions:

  • Age-specific ED95 reference doses for remimazolam tosilate in pediatric moderate sedation were established.
  • While remimazolam has a favorable safety profile, individualized dose titration is essential.
  • Particular attention and closer monitoring are warranted for toddlers due to a higher incidence of bradycardia.
Abstract

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...